[9] The Innovative Medicines Initiative is aimed towards removing research bottlenecks in the current drug development process.

The funding scheme has been criticised,[10] requiring universities to invest more money than with EU FP7 programs.

Besides the non-competitive financial aspects of participation in IMI projects for academia, this criticism also discusses that intellectual property is freely flowing to industry.

In September 2014 IMI-TRAIN, an IMI/ENSO-funded education and training collaboration to support biomedical scientists and professionals, has been launched.

IMI-TRAIN will serve as a collaboration platform for the currently IMI-funded education and training projects:[13]